Medical Cannabis Clinician Briefs: Pain Trio for Older Adults (Chronic Pain, Neuropathic Pain, Migraine; Nationwide Edition, PDF)

Pain is where the medical cannabis evidence is deepest. The National Academies graded the evidence for chronic pain in adults "conclusive or substantial", and a 2026 Cochrane review covers chronic neuropathic pain. Pain is also where patients' expectations most often run ahead of the evidence, especially for older adults.

This bundle brings together the three pain briefs from the Top 10 pack. The migraine brief notes that the 2017 report made no migraine-specific conclusion, and it cites a 2026 randomized trial and a 2026 systematic review instead.

Inside (8-page PDF):

- Three briefs: Chronic Pain & Arthritis · Neuropathic Pain · Migraine & Headache

- In each brief:

- An at-a-glance strip with four boxes:

- the National Academies evidence grade

- whether a Cochrane review exists

- the number of PubMed records in adults 65+

- the number of states with medical cannabis programs (41 states + DC, per NCSL)

- The National Academies (2017) conclusion, quoted word for word

- 8–10 verified sources, each tagged by type (NASEM, COCHRANE, PUBMED, NIH, STATE, LIST), with clickable PubMed and DOI links

- Four geriatric-considerations questions (falls, cognition, sedative load, renal/hepatic issues, polypharmacy, monitoring)

- Drugs.com interaction-checker links to review with a pharmacist

- A state-rules note: eligibility, certification and qualifying-condition lists vary by state, with a pointer to your state's official program in Appendix A

- Nationwide state program table and a sources and method page

Education only. These briefs are a research-navigation aid. They are not medical, legal or prescribing advice. They do not diagnose, prescribe, recommend products, set doses or titration, or give drug-interaction verdicts. Cited titles and conclusions are summarized for orientation only. Read the original sources before relying on any of them. Clinical decisions remain with the treating clinician. Confirm all laws and program rules on official state sites. For use with licensed, state-regulated medical cannabis programs only.

Sources include the National Academies of Sciences, Engineering, and Medicine (2017), Cochrane reviews, studies indexed in PubMed, NIH pages (NCCIH, NCI and others), the National Conference of State Legislatures (NCSL), and official state program sites. This is an independent guide and is not endorsed by any cited source. Prepared by Annie Romelfanger, author of Medical Cannabis Handbook: A Friendly Guide to Safe, Simple Healing. Last reviewed: October 2026. Corrections: romelfanger@proton.me.